CoverOne includes a Patient Assistance Program (PAP) that provides TEPMETKO® (tepotinib) at no charge to patients who meet certain insurance (i.e., uninsured), income, and residency eligibility criteria.
To determine patient eligibility, providers should complete and fax the CoverOne TEPMETKO Enrollment Form prior to treatment to 844-501-0062
An Access Navigator will notify you as soon as possible about the patient’s eligibility status.
If eligible, the CoverOne PAP will ship the free supply of TEPMETKO to the patient
NOTE: The CoverOne patient assistance program is a philanthropic program for patients in need, and is not contingent on any past or future commercial sale.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
You are about to leave the CoverOne website and are being redirected to a non-CoverOne website. EMD Serono does not review nor control the content of the following website. This redirection does not constitute an endorsement by EMD Serono of the following organization or any information provided by the organization.